Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001041180 | SCV001204781 | uncertain significance | Fanconi anemia | 2022-03-04 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 7 of the FANCM gene. It does not directly change the encoded amino acid sequence of the FANCM protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs370363591, gnomAD 0.008%). This variant has been observed in individual(s) with ovarian cancer (PMID: 28881617). ClinVar contains an entry for this variant (Variation ID: 839425). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV003223692 | SCV003919364 | uncertain significance | not provided | 2022-10-20 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Observed in an individual with ovarian cancer and in an unaffected control (Dicks et al., 2017); This variant is associated with the following publications: (PMID: 28881617) |